Evidence map›Paper›PMID 35754914›Full record

ArticleRSC advances2022

Near-perfect spectrally-selective metasurface solar absorber based on tungsten octagonal prism array.

Mingpan Xu, Lin Guo, Pengfei Zhang, Yu Qiu, Qing Li, Jikang Wang

Abstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Nanostructures/TiN layer/AlScientific reports · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingpan XuSchool of Energy Science and Engineering, Central South University Changsha Hunan 410083 China yu.qiu@csu.edu.cn qingli@csu.edu.cn.
Lin GuoEnergy Research Institute, Qilu University of Technology Jinan 250014 P. R. China.ORCID https://orcid.org/0000-0001-9880-7205
Pengfei ZhangSchool of Energy Science and Engineering, Central South University Changsha Hunan 410083 China yu.qiu@csu.edu.cn qingli@csu.edu.cn.
Yu QiuSchool of Energy Science and Engineering, Central South University Changsha Hunan 410083 China yu.qiu@csu.edu.cn qingli@csu.edu.cn.ORCID https://orcid.org/0000-0001-9836-036X
Qing LiSchool of Energy Science and Engineering, Central South University Changsha Hunan 410083 China yu.qiu@csu.edu.cn qingli@csu.edu.cn.ORCID https://orcid.org/0000-0002-6777-855X
Jikang WangSchool of Energy Science and Engineering, Central South University Changsha Hunan 410083 China yu.qiu@csu.edu.cn qingli@csu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solar selective absorbers influence the photothermal efficiency of high-temperature solar thermal applications directly and significantly. In present work, a metasurface absorber consisting of an octagonal prism array is proposed, optimized and analyzed. Firstly, the structure parameters of the absorber are optimized, finding the optimal absorber achieves near-perfect spectrally-selectivity compared with the perfect solar absorber. The high solar absorptivity of 0.9591, low emissivity of 0.1594-0.3694, and high photothermal efficiency of 94.72-83.10% are achieved at 1073-1573 K and 1000 suns. Then, the mechanisms leading to the excellent spectral selectivity are investigated, suggesting that the coupling effects of multi-plasmon resonance modes and the impedance matching lead to the high solar absorptivity. Meanwhile, the impedance mismatching is the mechanism to minimize the emissivity in the mid-IR region. Moreover, whether the spectral absorptivity can be changed by structural parameters is investigated, suggesting that the excircle diameter of the first tungsten octagonal prism and the height of SiO

Identifiers

PMID35754914
PMCPMC9172566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.